NCT06203106View on ClinicalTrials.gov

NYSCF Scientific Discovery Biobank

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

November 10, 2022

Primary Completion Date

November 10, 2045

Study Completion Date

November 10, 2045

Conditions
ALSAmyotrophic Lateral SclerosisAlzheimer DiseaseAlzheimer Disease, Early OnsetAlzheimer Disease, Late OnsetBatten DiseaseCorticobasal DegenerationDementiaFrontotemporal DementiaHuntington DiseaseLewy Body DiseaseMultiple SclerosisMultiple System AtrophyParkinson DiseaseParkinson's Disease and ParkinsonismProgressive Supranuclear PalsyINADDiabetesDiabetes MellitusDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Macular DegenerationOvarian CancerCervical CancerUterine CancerVaginal CancerVulvar CancerPTSDPost Traumatic Stress Disorder
Interventions
OTHER

Biological Sample Collection

Skin biopsy (2-3mm) and/or blood (up to 50 mL); saliva; excess/ leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure).

Trial Locations (1)

10019

RECRUITING

New York Stem Cell Foundation Research Institute, New York

All Listed Sponsors
lead

New York Stem Cell Foundation Research Institute

OTHER